This page is a permanent link to the reply below and its nested replies. See all post replies »
Valerian · 100+, M
✅ [big]I'm Fully Vaccinated as of early March 2021!👍🏻[/big]
I also have absolutely planned to receive the NVX-CoV2373 Vaccine from NovaVax as soon a it is Available!
[sep]
✅ The NovaVax COVID-19 vaccine is a PROTEIN-BASED VACCINE and [u]NOT one of the New Type of mRNA Vaccines[/u], which can become unstable unless kept very cold. Those New mRNA vaccines work by introducing a piece of mRNA to modify the DNA in your immune system.
✅ The NovaVax COVID-19 vaccine, codenamed NVX-CoV2373, is a subunit protein-based COVID-19 vaccine candidate developed by NovaVax in Gaithersburg, Maryland.
✅ The vaccine has [u]efficacy[/u] rates of [u]95 and 94 percent[/u] against the original coronavirus strain in Phase 3 trials, as compared with [u]96 percent efficacy[/u] for NovaVax in its first trial.
✅ In the 29,960-person trial, in the United States and Mexico, the vaccine demonstrated an overall efficacy of 90.4 percent, [u]on par[/u] with the vaccines made by Pfizer-BioNTech and Moderna, and [u]higher[/u] than the one-shot vaccine from Johnson & Johnson.
✅ The Novavax vaccine showed an efficacy of 100 percent at preventing moderate or severe disease.
✅ The Novavax vaccine also has a substantially lower rate of side effects than the authorized mRNA vaccines.
[b]
🆓 You may wish to Read these Articles: [/b]
https://www.theatlantic.com/health/archive/2021/06/novavax-now-best-covid-19-vaccine/619276/
https://www.nebraskamed.com/COVID/moths-and-tree-bark-how-the-novavax-vaccine-works
Theres a lot more articles you could look at as well.
I also have absolutely planned to receive the NVX-CoV2373 Vaccine from NovaVax as soon a it is Available!
[sep]
✅ The NovaVax COVID-19 vaccine is a PROTEIN-BASED VACCINE and [u]NOT one of the New Type of mRNA Vaccines[/u], which can become unstable unless kept very cold. Those New mRNA vaccines work by introducing a piece of mRNA to modify the DNA in your immune system.
✅ The NovaVax COVID-19 vaccine, codenamed NVX-CoV2373, is a subunit protein-based COVID-19 vaccine candidate developed by NovaVax in Gaithersburg, Maryland.
✅ The vaccine has [u]efficacy[/u] rates of [u]95 and 94 percent[/u] against the original coronavirus strain in Phase 3 trials, as compared with [u]96 percent efficacy[/u] for NovaVax in its first trial.
✅ In the 29,960-person trial, in the United States and Mexico, the vaccine demonstrated an overall efficacy of 90.4 percent, [u]on par[/u] with the vaccines made by Pfizer-BioNTech and Moderna, and [u]higher[/u] than the one-shot vaccine from Johnson & Johnson.
✅ The Novavax vaccine showed an efficacy of 100 percent at preventing moderate or severe disease.
✅ The Novavax vaccine also has a substantially lower rate of side effects than the authorized mRNA vaccines.
[b]
🆓 You may wish to Read these Articles: [/b]
https://www.theatlantic.com/health/archive/2021/06/novavax-now-best-covid-19-vaccine/619276/
https://www.nebraskamed.com/COVID/moths-and-tree-bark-how-the-novavax-vaccine-works
Theres a lot more articles you could look at as well.